Impetigo herpetiformis: A rare pregnancy-specific dermatosis

被引：1

作者：

Abdelhafez, Mohsen M. A. ^{[1
]}

Ahmed, Karim A. M. ^{[2
]}

Daud, Mohd Nazri Bin Mohd ^{[3
]}

Jeffree, Mohammad Saffree ^{[4
]}

Kadir, Fairrul ^{[5
]}

Baharuddin, Dg Marshitah Pg ^{[1
]}

Than, Win Win ^{[1
]}

Hayatti, Firdaus ^{[6
]}

Tay, Kai Xin ^{[7
]}

Eldiastey, Aya M. ^{[8
]}

机构：

[1] Univ Malaysia Sabah, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Kota Kinabalu, Malaysia

[2] Helios St Johannes Klinikum, Dept Dermatol, Duisburg, Germany

[3] Univ Malaysia Sabah, Fac Med & Hlth Sci, Dept Publ Hlth Med, Family Med Unit, Kota Kinabalu, Malaysia

[4] Univ Malaysia Sabah, Fac Med & Hlth Sci, Dept Publ Hlth Med, Kota Kinabalu, Malaysia

[5] Univ Malaysia Sabah, Fac Med & Hlth Sci, Dept Emergency Med, Kota Kinabalu, Malaysia

[6] Univ Malaysia Sabah, Fac Med & Hlth Sci, Dept Surg, Kota Kinabalu, Sabah, Malaysia

[7] Univ Malaysia Sabah, Fac Business Econ & Accountancy, Kota Kinabalu, Malaysia

[8] Ain Shams Univ, Fac Med, Cairo, Egypt

来源：

OBSTETRIC MEDICINE | 2023年 / 16卷 / 01期

关键词：

pregnancy dermatosis; late pregnancy; erythematous plaques; pustules; fetal growth restriction; placental insufficiency; GENERALIZED PUSTULAR PSORIASIS; CYCLOSPORINE; MUTATIONS; THERAPY;

D O I：

10.1177/1753495X221074610

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Impetigo herpetiformis (IH) is a pregnancy-specific dermatosis that is currently considered a form of generalised pustular psoriasis and mainly occurs in late pregnancy during the third trimester. IH presents as erythematous patches and pustules and might have systemic involvement. The disease may be associated with severe maternal, fetal, and neonatal complications. IH treatment is very challenging, however, various therapeutic options are available and effective for disease treatment.

引用

页码：5 / 8

页数：4

共 34 条

[1] Pregnancy outcome after cyclosporine therapy during pregnancy: A meta-analysis [J].

Bar-Oz, B ;

Hackman, R ;

Einarson, T ;

Koren, G .

TRANSPLANTATION, 2001, 71 (08) :1051-1055

[2] A case of recurrent impetigo herpetiformis treated with systemic corticosteroids and narrowband UVB [J].

Bozdag, Kubra ;

Ozturk, Serap ;

Ermete, Murat .

CUTANEOUS AND OCULAR TOXICOLOGY, 2012, 31 (01) :67-69

[3]

Bukhari Iqbal A, 2004, J Drugs Dermatol, V3, P449

[4] Maternal corticosteroid use and orofacial clefts [J].

Carmichael, Suzan L. ;

Shaw, Gary M. ;

Ma, Chen ;

Werler, Martha M. ;

Rasmussen, Sonja A. ;

Lammer, Edward J. .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) :585.e1-585.e7

[5] Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy [J].

Chambers, Christina D. ;

Johnson, Diana L. .

BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2012, 94 (08) :607-611

[6] Impetigo herpetiformis: a rare dermotosis of pregnancy [J].

El Fiboumi, Amal ;

Chiheb, Soumya .

PAN AFRICAN MEDICAL JOURNAL, 2018, 30

[7]

Erbagci Z, 2000, INT J CLIN PRACT, V54, P619

[8]

Fouda Usama M, 2009, Cases J, V2, P9338, DOI 10.1186/1757-1626-2-9338

[9] Impetigo Herpetiformis during Pregnancy: A Case Report and Literature Review [J].

Gao, Qian-Qian ;

Xi, Ming-Rong ;

Yao, Qiang .

DERMATOLOGY, 2013, 226 (01) :35-40

[10]

Guerriero C, 2008, J BIOL REG HOMEOS AG, V22, P141

← 1 2 3 4 →